NCT06984926View on ClinicalTrials.gov

A Study to Test How Well Multiple Doses of BI 3810477 Are Tolerated by Healthy Adults

PHASE1RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

June 6, 2025

Primary Completion Date

March 9, 2026

Study Completion Date

March 9, 2026

Conditions
Healthy
Interventions
DRUG

BI 3810477

BI 3810477

DRUG

Placebo

Placebo for BI 3810477

Trial Locations (1)

2650

RECRUITING

SGS Life Science Services - Clinical Research, Edegem

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY